Delivery Order SPE2DB20D1050-SPE2DB24FH60V
Award Date
4/15/24
Potential Completion Date
4/16/24
Potential Value
$8.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation, is for the delivery of 4,564,535,197 units of Lidocaine 5% Patch 30s to the Defense Logistics Agency (DLA). The single-award Indefinite Delivery Contract (IDC) is valued up to $999,999,999.00 and runs through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,977,761 units of Lidocaine 5% Patch 30s, a pharmaceutical product, to the Defense Logistics Agency (DLA) over a period ending on June 24, 2024. The contract has a ceiling value of $1,609.10 and is a firm fixed-price delivery order contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,339,361 units of Lidocaine 5% Patch 30s, a pharmaceutical product. The $1,700.37 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of April 22, 2024. The award is not associated with a set-aside program. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the...
This federal contract award, valued at $13,611.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, as a prime contractor. The contract is for the delivery of 4564185827 - Lidocaine 5% Patch 30s, a pharmaceutical product, to support military treatment programs and facilities. The contract has a firm fixed price pricing type and a period of performance through April 8, 2024. No set-aside designation was used for this...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order worth $1,315.20 for the supply of 4,564,360,453 units of Lidocaine 5% Patch 30s. The award was made by the Defense Logistics Agency (DLA), a defense agency, for the delivery of these pharmaceutical products by April 23, 2024. This contract does not have a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, is for the delivery of 4,564,674,922 units of Lidocaine 5% Patch 30s medication. The $4,648.86 firm fixed-price delivery order was awarded on May 21, 2024 by the Defense Logistics Agency (DLA), with a period of performance through May 22, 2024. This contract is not designated as a set-aside. Amerisourcebergen is a major supplier of pharmaceutical products and medical...
This federal contract award, valued at $23,363.75, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the provision of Lidocaine 5% patches, a pharmaceutical product, on a firm fixed price basis. The contract has an ultimate completion date of March 19, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the supply of Lidocaine 5% Patches. The contract has a ceiling value of $1,287.86 and a completion date of May 29, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,977,871 units of Lidocaine 5% Patch 30S. The award, valued at $3,379.81, was issued by the Defense Logistics Agency (DLA) on June 21, 2024, with a completion date of June 24, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $8,258.16 firm fixed-price delivery order is for the supply of 4,565,020 units of Lidocaine 5% Patch. The contract has an ultimate completion date of June 28, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025....